- Advertisement -
India is expressing concerns over a crucial decision set to be made by former U.S. President Donald Trump on April 2. Trump has announced plans to impose a 25% tariff on medicines exported from India to the United States. A final decision on this matter is expected to be announced on Wednesday. India exports medicines worth $30 billion annually, with one-third of that value being shipped to the U.S. While Indian exports to the U.S. currently face minimal tariffs, India itself imposes a 10% duty on products imported from the U.S.
